FDA-2024-0021-V421

Type IA variation for application FDA-2024-0021. Type IA variation: Specification Change for Kcluximab — minor update

Variation Number
FDA-2024-0021-V421
Type
Type IA
Application
FDA-2024-0021
Change
CHG-2024-0121
Status
Approved
Fee
€1,982
Submitted
2023-12-05
Approved
2024-07-04
Description

Type IA variation: Specification Change for Kcluximab — minor update